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Available online 27 August 2011Phytochemical investigation on Clusia burlemarxii (Clusiaceae) led to isolation and identification
of nine compounds. Were isolated from leaves 3-O-α-L- rhamnopyranosylquercetin, 3-O-α-L-
rhamnopyranosylkaempferol, 4-hydroxy-5,5-dimethyldihydrofuran-2-one, 2Z-δ-tocotrienoloic
acid and friedelin and were isolated from trunk betulinic acid, protocatechuic acid, lyoniresinol,
and a new biphenyl 2,2-dimethyl-3,5-dihydroxy-7-(4-hydroxyphenyl)chromane. The structures
were determined by 1H, 13C-NMR, DEPT, HMBC, HMQC, HRESIMS. The Minimal Inhibitory Con-
centration against Streptococcusmutans, Staphylococcus aureus, Bacillus subtilis,Micrococcus luteus,
Escherichia coli, Salmonella choleraesuis, Pseudomonas aeruginosa, Aspergillus niger and Cladospor-
ium cladosporioides was also determined. Extracts and compounds showed significant activity
against tested Gram-positive bacteria, none activity against tested Gram-negative bacteria and
fungi.
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Clusiaceae is a tropical and temperate family of around 43
genera and 1610 species. In Brazil, there are 21 genera and
about 180 species with wide occurrence [1]. Many plants be-
longing to this family have been used by traditional medicine
in different regions of the world [2–5] whose extracts and
pure compounds have shown antibacterial [6], antifungic
[7,8], antiviral [9] e antitumoral activities [10–15].
The genus Clusia is constituted of about 200 species and its
occurrence is restricted to tropical and subtropical regions of
South and Central America [1]. The species of this genus are
known as producers of polyprenilated benzophenones and tri-
terpenes [16–18]. Biphenyls [15,18,19], quinones [20] and
tocotrienols [18,21] are rarely found. Lignans were never
found in the genus; in the family only two, syringaresinol
from roots of Vismia guaramirangae [22] and kaerophyllin
fromMontrouziera sphaeroidea [23] were previously described.
Clusia burlemarxii is a wild shrub with distribution restricted
to campo rupestre areas (rocky fields) of Chapada Diamantina,x: +55 71 32374117.
lsevier OA license. Bahia, Brazil. Phytochemical investigation on this species led
to isolation and identification of nine compounds: 3-O-α-L-
rhamnopyranosylquercetin, 3-O-α-L-rhamnopyranosylkaemp-
ferol, 4-hydroxy-5,5-dimethyldihydrofuran-2-one, 2Z-δ-toco-
trienoloic acid, and friedelin were isolated from leaves, and
betulinic acid, protocatechuic acid, lyoniresinol and a newbiphe-
nyl 2,2-dimethyl-3,5-dihydroxy-7-(4-hydroxyphenyl)chromane
were isolated from trunk. As a part of our search for new source
of antimicrobial compounds, in vitro preliminary tests were per-
formed to determine the inhibitory activity of extracts and pure
compounds against Streptococcus mutans, Staphylococcus aureus,
Bacillus subtilis, Micrococcus luteus, Escherichia coli, Salmonella
choleraesuis, Pseudomonas aeruginosa, Aspergillus niger and Cla-
dosporium cladosporioides.2. Experimental
2.1. General procedures
Optical rotations were measured on a Perkin-Elmer model
341 digital polarimeter. NMR spectra were recorded on a
VARIAN GEMINI 2000 spectrometer operating at 300 MHz.
Table 1
1H NMR (300 MHz) and 13C NMR (75 MHz) data for compound 1 in
(CD3)2CO (δ in ppm and J in Hz).
No. δH δC
1 – 140.9
2 6.47 (1H, d, J=1.7) 106.8
3 – 155.2
4 – 107.2
5 – 156.8
6 6.62 (1H, d, J=1.7) 105.2
7 – 133.1
8, 12 7.39 (2H, d, J=8.7) 128.4
9, 11 6.87 (2H, d, J=8.7) 116.3
10 – 157.8
2′ – 77.4
3′ 3.78 (1H, dd, J=8.1 5.7) 69.9
4′ 2.54 (1H, dd, J=17.1 8.1)
2.94 (1H, dd, J=17.1 5.7)
27.1
5′ 1.23 (3H, s) 20.2
6′ 1.35 (3H, s) 26.1
OH-5 8.60 (1H, bs) –
OH-10 8.60 (1H, bs) –
OH-3′ 4.27 (1H, bs) –
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ker Daltonics (Billa Rica, USA). CC was performed using silica
gel (230–400 mesh). TLC was carried out by using silica gel
plates prepared with GF254+366 (Merck); spots were visual-
ized by UV light or iodine vapor.
2.2. Plant material
C. burlemarxiiwas collected in campo rupestre areas (rocky
fields) in Mucugê, Bahia, northeastern region of Brazil. The
voucher specimen (ALCB-61584) is stored at Alexandre Leal
Costa herbarium of the Biology Institute, UFBA.
2.3. Extraction and isolation
The dried and powdered leaves (1.6 kg) were extracted by
three timesmacerationwith 95% ethanol at room temperature.
The combined extract was concentrated under reduced pres-
sure at 40 °C and then it was dissolved in a mixture of ethanol
andwater (8:2). This solution was successively extracted three
times with hexane yielding 2.54 g, and three times with EtOAc
yielding 3.52 g. The dried and powdered trunk (3.9 kg) was
extracted by maceration three times with methanol at room
temperature. The concentrated methanol extract was parti-
tioned with hexane yielding to 3.63 g and with EtOAc yielding
12.61 g.
The ethyl acetate extract (3.52 g) of leaves was subjected to
a CC over silica gel using as eluent mixtures of chloroform and
methanol of increasing polarity. Eighteen fractions were
obtained. From fraction 1, by recrystallization inmethanol, frie-
delin (8 mg) was isolated [24]. The second fraction (120 mg)
was subjected to CC on silica gel using as eluent mixtures of
ethyl acetate and methanol of increasing polarity providing 4-
hydroxy-5,5-dimethyldihydrofuran-2-one [25] (10 mg) and
2Z-δ-tocotrienoloic acid (5 mg) [18]. Combined fractions 14–
17 (350 mg)were subjected to a CC on silica gel using as eluent
mixtures of chloroform and methanol of increasing polarity
yielding 3-O-α-L- rhamnopyranosylquercetin (20 mg) and 3-
O-α-L-rhamnopyranosylkaempferol (30 mg) [26].
The ethyl acetate extract (12.61 g) from the trunk was
subjected to filtration on a CC over silica gel using as eluent
mixtures of dichloromethane and ethyl acetate gradient of
increasing polarity. Twenty one fractions were obtained.
The fractions CBM1-13 to CBM1-15 were grouped (330 mg)
and then fractionated on a CC of silica gel using as eluting sys-
tem mixtures of dichloromethane and ethyl acetate yielding
53 fractions. From fractions CBM2-36 to CBM2-40 the proto-
catechuic acid was isolated (20 mg). The fractions CBM2-42
to CBM2-46 were grouped (60 mg) and submitted to a TLC
over silica gel eluted with chloroform:methanol (85:15)
yielding (+)-lyoniresinol (20 mg) [27]. The fractions CBM1-
16 to CBM1-21 after being grouped (9 g) were subjected to
liquid–liquid extractions, three times with dichloromethane
and then three times with ethyl acetate. The material
extracted with dichloromethane (2 g) was subjected to a col-
umn of silica gel eluted with mixtures of dichloromethane
and acetone in increasing polarity gradient leading to two
substances, betulinic acid [28] (30 mg) and a new biphenyl
2,2-dimethyl-3,5-dihydroxy-7-(4-hydroxyphenyl)chromane,
1 (12 mg).(−)-2,2-dimethyl-3,5-dihydroxy-7-(4-hydroxyphenyl)
chromane (1): Yellow greenish semi-solid; [α]D25-103,45
(c 0.29, CH3OH). RMN 1H e 13C, see Table 1. HREIMS: m/z
309.1153 [M+Na]+.
2.4. Antimicrobial tests
The determination of minimum inhibitory concentration
(MIC) of extracts and isolated compounds was performed by
using the successivemicrodillution test in 96wells plate accord-
ing to the methodology of Bicalho et al. (2003) [29]. Nutrient
broth and malt were used as culture media for bacteria and
fungi, respectively. The stock solutions of sampleswere prepared
bydissolving2 mgof pure substance or 8 mgof extract in 5 ml of
dimethylsulfoxide in water (20% v/v). Chloramphenicol and
ciclopirox olamine (Loprox) were used as positive control for
bacteria and fungi, respectively, in the same concentration of
stock solution (2000 μg ml−1 for extract and 400 μg ml−1 for
pure substances). The concentrations of samples and positive
controls ranged from 500 μg ml−1 to 3.90 μg ml−1 for the ex-
tracts and from 100 μg ml−1 to 0.78 μg ml−1 for the pure sub-
stances. The incubation period was 24 h for bacteria and 72 h
for fungi.MICwas determined through the emergence of turbid-
ity in the wells. Nine microbial strains were used to access the
antimicrobial properties of the test sample: the bacteria
S. mutans (ATCC 5175), S. aureus (ATCC 6538), B. subtilis (ATCC
6633),M. luteus (ATCC 10240), E. coli (ATCC 94863), S. cholerae-
suis (ATCC 14028), P. aeruginosa (clinical isolate) and the fungi
Aspergillus ninger (ATCC 16 404) and C. cladosporioides (IMI
178 517). All tests were performed in triplicate. Extracts were
considered active when there was inhibition at concentrations
below or equal to 500 μg ml−1. The substances were considered
active when there was inhibition at concentrations below or
equal to 100 μg ml−1.
3. Results and discussion
The structures of compounds were determined using 1H
and 13NMR, DEPT, HMQC, HMBC and MS and by comparison
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Fig. 1. Structure of compound 1 showing selected HMBC correlations.
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obtainedwhere friedelin, 3-O-α-L- rhamnopyranosylquercetin
and 3-O-α-L-rhamnopyranosylkaempferol are commonly
found in plants. The 4-hydroxy-5,5-dimethyldihydrofuran-2-
one is very rare in plants and this is the first report to the family
Clusiaceae. The 2Z-δ-tocotrienoloic acid is also rarely found in
the family where the E isomer is the most common. From
trunk, four compounds were isolated where betulinic acid
and protocatechuic acid are common in plants. However, lig-
nans are very rare in the family where the (+)-lyoniresinol is
the third lignan isolated in Clusiaceae. Biphenyls have some oc-
currence related in the family and this is the first report for the
compound 2,2-dimethyl-3,5-dihydroxy-7-(4-hydroxyphenyl)
chromane.
The 1H NMR spectra of 1 showed two doublets of two hy-
drogen at δ 6.47 (1.7 Hz) and δ 6.62 (1.7 Hz) suggesting the
presence of a 1,3,4,5-tetrasubstituted aromatic ring. Additional-
ly, it showed two doublets of two hydrogen each at δ 6.87
(8.7 Hz) and δ 7.39 (8.7 Hz) suggesting the presence of another
aromatic ring with 1,4 substitution pattern. Two singlets at δ
1.23 and δ 1.35 for three hydrogen each were assigned to a
gem-dimethyl group. A double doublet at δ 3.78 (8.1 and
5.7 Hz) suggested the presence of a methyne oxygenated
group attached to a methylene group. Two double doublets at
δ 2.54 (17.1 and 8.1 Hz) and δ 2.94 (17.1 and 5.7 Hz), con-
firmed the presence of an α-carbinolic methylene group. The
13C NMR data indicated six non-hydrogenated aromatic car-
bons including three oxygenated at δ 157.8, δ 156.8 and δ
155.2 besides signals of four aromatic hydrogenated carbons,
where two of them, those at δ 128.4 and δ 116.3, corresponded
to two CH each. In the aliphatic region of spectrum signalswere
observed at δ 77.4 (C), δ 69.9 (C), δ 27.1 (CH2), δ 26.1 (CH3), andHO
O
SCoA
O
3 x
malonyl-CoA
+ OH
O
ACoS
4-hydroxybenzoyl-CoA
OH
HO
O
HO
1
O
O
A
HO
HO
O
. .
Fig. 2. Proposed biosynthesis of compound 1. BISδ 20,2 (CH3) compatible with a 2,2-dimethylpyran group with
a hydroxyl at C-3. The J values observed for H-3′ (Table 1) indi-
cated that the pyran ring assumes a half-chair conformation in
which H-3′ is pseudo-axial.
DEPT and 13C NMR data analysis indicated the presence of
two methyl, one methylene, seven methyne and seven non-
hydrogenated carbons. Based on these data and in the pseudo
molecular ion peak atm/z 309.1153 [M+Na]+ the molecular
formula, C17H18O4 was deduced to compound 1.
The HMBC data (Fig. 1) indicated that compound 1 is a bi-
phenyl with a 3′-hydroxi-2′,2′-dimethylpyran moiety located
at C-3 and C-4 and with two additional hydroxyl groups at C-
5 and C-10. The correlations of H-2 with C-3 and C-7, the cor-
relations of H-6 with C-5 and C-7, the correlations of H-9
with C-7 and C-10 and the correlations of H-4′ with C-3 and
C-4 determined unequivocally the localization of substituent
groups in the biphenyl skeleton. A similar compound pre-
senting in C-5 a methoxyl group instead of a hydroxyl was
isolated from roots of Garcinia linii [30].
Biphenyls are substances found mainly in plants of Rosaceae
[31–33] in which they are identified as phytoalexins. In Clusia
they are rare and in literature the isolation of five from C. parali-
cola [15,19] and one from C. melchiorii [18] was reported. Com-
pound 1 was probably biosynthesized through the action of a
biphenyl synthase in an intermediary produced by the conden-
sation of 4-hydroxybenzoyl-CoA, derived from 4-coumaroyl-
CoA, with three acetyl units, derived from malonyl-CoA [34].
The enzyme catalyzes the cyclization of the intermediary via an
intramolecular aldol condensation followedby a CO2 elimination
producing the 3,4,10-trihydroxybiphenyl. A prenyltransferase
promoted a prenylation of C-4 with subsequent epoxidation of
double bond and cyclization to produce compound 1 (Fig. 2).
The antimicrobial activities of substances and extracts
were assayed against four Gram-positive bacteria (S. aureus,
S. mutans, B. subtilis andM. luteus), three Gram-negative bac-
teria (E. coli, S. choleraesuis and P. aeruginosa) and two fungi
(A. niger and C. cladosporioides).
The MIC obtained in the initial assessment of C. burlemarxii
extracts demonstrated a very promising activity from the
leaves ethanol extract against B. subtilis (31.25 μg ml−1) and
S. aureus (62.50 μg ml−1) and from the trunkmethanol extract
against B. subtilis (62.50 μg ml−1), S. mutans (62.50 μg ml−1)
andM. luteus (31.25 μg ml−1).
The antimicrobial activity of the isolated compounds
showed that compound 1 exhibited significant activity against
all tested Gram positive bacteria which was stronger against
M. luteus (25 μg ml−1) and S. aureus (50 μg ml−1) and weakerOH
HO
HO
- CO2
OH
HO
HO
PT
O
CoS
O
[O]OH
BIS
, biphenyl synthase; PT, prenyltransferase.
1240 P.R. Ribeiro et al. / Fitoterapia 82 (2011) 1237–1240against B. subtilis (100 μg ml−1) and S. mutans (100 μg ml−1).
Lyoniresinol and 3-O-α-L-rhamnopyranosylkaempferol were
more selective showing strong activity only against S. aureus
(25 μg ml−1) whereas 3-O-α-L- rhamnopyranosylquercetin
exhibited moderate activity only against B. subtilis
(50 μg ml−1) and was weaker against S. aureus (100 μg ml−1).
The other compounds showed no activity against the microor-
ganisms tested. Neither extracts nor compounds showed activi-
ty against tested Gram negative bacteria and fungi.
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